Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2018.1264
Abstract: Importance Hemophagocytic lymphohistiocytosis (HLH) has been reported as a serious complication of cutaneous T-cell lymphoma (CTCL). Despite available diagnostic guidelines, it remains a diagnostic and therapeutic challenge in this patient population. Objectives To examine the… read more here.
Keywords: cutaneous cell; hemophagocytic lymphohistiocytosis; cell; hlh ... See more keywords
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.3347
Abstract: Importance There is a knowledge gap about subcutaneous panniculitis-like T-cell lymphoma (SPTCL) owing to its rarity and diagnostic difficulty, resulting in an absence of well-documented large case series published to date. Objective To generate consensus… read more here.
Keywords: cell; clinical pathological; cell lymphoma; subcutaneous panniculitis ... See more keywords
Risk of Anaplastic Large Cell Lymphoma Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Ductal Carcinoma in Situ
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.43396
Abstract: This cohort study examines the risk of anaplastic large cell lymphoma (ALCL) following postmastectomy implant reconstruction among US women with breast cancer and ductal carcinoma in situ (DCIS). read more here.
Keywords: risk anaplastic; cell lymphoma; postmastectomy implant; large cell ... See more keywords
Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2022.3236
Abstract: Using SEER database data, this cohort study analyzed cutaneous T-cell lymphoma incidence by tumor subtype, sex, age, race and ethnicity, socioeconomic status, and geography. read more here.
Keywords: cell lymphoma; incidence trends; cutaneous cell;
Breast Implant–Associated Anaplastic Large Cell Lymphoma: A Systematic Review
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2017.4026
Abstract: Importance Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), a rare peripheral T-cell lymphoma, is increasing in incidence. However, many practitioners who treat patients with breast cancer are not aware of this disease. Objectives To assess… read more here.
Keywords: breast implant; associated anaplastic; review; implant associated ... See more keywords
TrkA is a binding partner of NPM‐ALK that promotes the survival of ALK + T‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Oncology"
DOI: 10.1002/1878-0261.12088
Abstract: Nucleophosmin‐anaplastic lymphoma kinase‐expressing (NPM‐ALK+) T‐cell lymphoma is an aggressive neoplasm that is more commonly seen in children and young adults. The pathogenesis of NPM‐ALK+ T‐cell lymphoma is not completely understood. Wild‐type ALK is a receptor… read more here.
Keywords: alk cell; alk; npm alk; cell ... See more keywords
Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD‐L1 and predicts poor prognosis in B‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2020 at "Molecular Oncology"
DOI: 10.1002/1878-0261.12664
Abstract: B‐cell non‐Hodgkin's lymphoma (NHL) is a class of heterogeneous diseases with variable clinical outcomes. Immunosuppression is particularly common in the subtypes of lymphoma with poor prognosis, but the underlying mechanism remains unclear. Using a RT‐PCR… read more here.
Keywords: poor prognosis; glt1d1; overexpression glt1d1; cell ... See more keywords
Incidence, clinical findings, and survival of hepatosplenic T‐cell lymphoma in the United States
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Hematology"
DOI: 10.1002/ajh.24711
Abstract: thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000;111(2):467–473. [7] Levy A, Fraser D, Katz M, Mazor M, Sheiner E. Maternal anemia during pregnancy is an independent risk factor for low… read more here.
Keywords: survival hepatosplenic; incidence clinical; hepatosplenic cell; clinical findings ... See more keywords
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hematology"
DOI: 10.1002/ajh.25757
Abstract: Urelumab, a fully human, non‐ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T‐cell and natural killer‐cell antitumor activity in preclinical models, and may enhance cytotoxic activity of rituximab. Here we report results in patients with… read more here.
Keywords: relapsed refractory; combination; patients relapsed; cell ... See more keywords
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hematology"
DOI: 10.1002/ajh.25783
Abstract: Immunochemotherapy followed by autologous transplant (ASCT) in CALGB/Alliance 59909 achieved a median progression‐free survival (PFS) in mantle cell lymphoma (MCL) of 5 years, but late recurrences occurred. We evaluated tolerability and efficacy of adding post‐transplant bortezomib… read more here.
Keywords: pfs; calgb alliance; mantle cell; cell ... See more keywords
Hiding in (Not So) Plain Sight: Spontaneous Tumor Lysis Syndrome due to Intravascular Large B Cell Lymphoma.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of hematology"
DOI: 10.1002/ajh.26383
Abstract: Tumor lysis syndrome (TLS) is an oncologic emergency characterized by metabolic derangements (e.g., hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia) and clinical complications (e.g., renal failure, cardiac arrhythmia, new-onset seizure). It most often occurs in the setting… read more here.
Keywords: lysis syndrome; cell lymphoma; intravascular large; tumor lysis ... See more keywords